Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Hehua Xiong"'
Autor:
Xin Sun, Zunhua Yang, Qian Zhang, Xiaobo Liu, Pengwu Zheng, Binliang Zhang, Wufu Zhu, Shan Xu, Hehua Xiong
Publikováno v:
New Journal of Chemistry. 44:9053-9063
Two series of [1,2,4]triazolo[4,3-a]pyrazine derivatives bearing 4-oxo-pyridazinone moieties (compounds 21a–l and 22a–l) were designed and their IC50 values were evaluated against three cancer cell lines (A549, MCF-7 and HeLa) and c-Met kinase. A
Publikováno v:
Bioorganicmedicinal chemistry letters. 30(9)
A series of 4-(pyridin-4-yloxy)benzamide derivatives bearing a 5-methylpyridazin-3(2H)-one fragment were designed, synthesized, and evaluated for their biological activity. Most compounds showed effective inhibitory activity against cancer cell lines
Autor:
Zhen Xiao, Ping Gong, Duan Yongli, Qidong Tang, Linxiao Wang, Yinhua Xiong, Pengwu Zheng, Wufu Zhu, Shunmin Huang, Yueyue Xiao, Hehua Xiong, Ting Chen
Publikováno v:
European Journal of Medicinal Chemistry. 158:201-213
A series of 6,7-disubstituted-4-phenoxyquinoline derivatives bearing the 1,8-naphthyridin-2-one moiety were designed, synthesized and evaluated for their biological activities. The target compounds exhibited moderate to high antiproliferative activit
Autor:
Bingbing Zhao, Caolin Wang, Duan Yongli, Shifan Cai, Pengwu Zheng, Linxiao Wang, Yiqing Peng, Hehua Xiong, Shan Xu, Ping Wang, Qidong Tang, Rong Luo
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 28:254-259
A series of 2-substituted-4-phenoxypyridine derivatives were designed, synthesized, and evaluated for their antiproliferative activity against 4 cancer cell lines (A549, HT-29, H460, and U87MG) in vitro. Most compounds showed moderate to excellent po
Autor:
Manli Zhang, Bingliang Zhang, Hehua Xiong, Zhen Xiao, Jiayi Hu, Bingbing Zhao, Caolin Wang, Ouyang Yiqiang, Pengwu Zheng, Wufu Zhu, Yanli Gao, Shan Xu
Publikováno v:
New Journal of Chemistry. 42:17203-17215
Six series of quinazoline derivatives bearing oxazole or imidazole (8a–f, 9a–f, 10a–d, 11a–f, 12a–d and 13a–i) were designed, synthesized and their IC50 values evaluated against three cancer cell lines (A549, MCF-7 and PC-3). Most of the
Autor:
Pengwu Zheng, Ting Chen, Qidong Tang, Shunmin Huang, Jianqing Zhang, Huimin Liu, Hehua Xiong, Yongli Duan
Publikováno v:
Bioorganicmedicinal chemistry letters. 30(2)
A series of pyrrolo[2,3-b]pyridine derivatives bearing 4-oxoquinoline moiety were designed, synthesized and evaluated for the anti-proliferative on three cancer cell lines (A549, HepG2 and MCF-7) in vitro. Most of the compounds showed moderate to hig
Autor:
Yongli Duan, Pengqin Chen, Jianqing Zhang, Yao Zeng, Hehua Xiong, Guang Liang, Di Wu, Qidong Tang, Hongmin Li
Publikováno v:
European Journal of Medicinal Chemistry. 215:113273
In this study, a series of pyrrolo [2,3-d]pyrimidine derivatives containing 1,8-naphthyridine-4-one fragment were synthesized and their biological activity were tested. Most of the target compounds displayed moderate to excellent activity against one
Autor:
Jianqing Zhang, Hehua Xiong, Qidong Tang, Dongxue Fu, Feiyi Yang, Ting Chen, Jie He, Pengwu Zheng
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 33:127740
Cancer is a major cause of death worldwide. Small molecule inhibitors have become a major therapeutic treatment for cancer. In this study, a series of novel 4-(pyrrolo[2,3-d]pyrimidine-4-yloxy)benzamide derivatives were designed, synthesized and eval
Autor:
Wufu Zhu, Linxiao Wang, Xiaobo Liu, Hehua Xiong, Pengwu Zheng, Wensheng Zou, Xiuying Chen, Qidong Tang, Shan Xu, Shanshan Hou
Publikováno v:
Bioorganic chemistry. 77
Five series of N-methylpicolinamide moiety and thienopyrimidine moiety bearing triazole (21–26, 27–34, 35–41, 42–47 and 48–54) were designed and synthesized. And all the target compounds were evaluated for the IC50 values against three canc
Autor:
Qidong Tang, Jianxin Cheng, Zhen Xiao, Han Zhang, Pengwu Zheng, Jianqing Zhang, Hehua Xiong, Qian Zhang
Publikováno v:
Molecules
Volume 25
Issue 1
Volume 25
Issue 1
A series of 4-(pyridin-4-yloxy)benzamide derivatives containing a 1,2,3-triazole fragment were designed, synthesized, and their inhibitory activity against A549, HeLa, and MCF-7 cancer cell lines was evaluated. Most compounds exhibited moderate to po